tetano
Editor, Senior Moderator
Cell Commun Signal
. 2024 Feb 15;22(1):126.
doi: 10.1186/s12964-023-01316-9. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi[SUP] 1 [/SUP], Bahareh Hajikhani[SUP] 2 [/SUP], Paniz Azizi[SUP] 3 [/SUP], Fatemeh Aziziyan[SUP] 4 [/SUP], Mohsen Nabi-Afjadi[SUP] 4 [/SUP], Marzieh Ramezani Farani[SUP] 5 [/SUP], Hamidreza Zalpoor[SUP] 6 7 [/SUP], Maryam Azarian[SUP] 8 [/SUP], Mahdiyar Iravani Saadi[SUP] 9 [/SUP], Behrouz Gharesi-Fard[SUP] 10 [/SUP], Evangelos Terpos[SUP] 11 [/SUP], Iman Zare[SUP] 12 [/SUP], Mohammad Motamedifar[SUP] 13 14 [/SUP]
Affiliations
Extensive research in countries with high sociodemographic indices (SDIs) to date has shown that coronavirus disease 2019 (COVID-19) may be directly associated with more severe outcomes among patients living with haematological disorders and malignancies (HDMs). Because individuals with moderate to severe immunodeficiency are likely to undergo persistent infections, shed virus particles for prolonged periods, and lack an inflammatory or abortive phase, this represents an overall risk of morbidity and mortality from COVID-19. In cases suffering from HDMs, further investigation is needed to achieve a better understanding of triviruses and a group of related variants in patients with anemia and HDMs, as well as their treatment through vaccines, drugs, and other methods. Against this background, the present study aimed to delineate the relationship between HDMs and the novel COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Besides, effective treatment options for HDM cases were further explored to address this epidemic and its variants. Therefore, learning about how COVID-19 manifests in these patients, along with exploiting the most appropriate treatments, may lead to the development of treatment and care strategies by clinicians and researchers to help patients recover faster. Video Abstract.
Keywords: Anemia; COVID-19; Haematological disorders and malignancies; Immune response; SARS-CoV-2.
. 2024 Feb 15;22(1):126.
doi: 10.1186/s12964-023-01316-9. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi[SUP] 1 [/SUP], Bahareh Hajikhani[SUP] 2 [/SUP], Paniz Azizi[SUP] 3 [/SUP], Fatemeh Aziziyan[SUP] 4 [/SUP], Mohsen Nabi-Afjadi[SUP] 4 [/SUP], Marzieh Ramezani Farani[SUP] 5 [/SUP], Hamidreza Zalpoor[SUP] 6 7 [/SUP], Maryam Azarian[SUP] 8 [/SUP], Mahdiyar Iravani Saadi[SUP] 9 [/SUP], Behrouz Gharesi-Fard[SUP] 10 [/SUP], Evangelos Terpos[SUP] 11 [/SUP], Iman Zare[SUP] 12 [/SUP], Mohammad Motamedifar[SUP] 13 14 [/SUP]
Affiliations
- PMID: 38360719
- DOI: 10.1186/s12964-023-01316-9
Extensive research in countries with high sociodemographic indices (SDIs) to date has shown that coronavirus disease 2019 (COVID-19) may be directly associated with more severe outcomes among patients living with haematological disorders and malignancies (HDMs). Because individuals with moderate to severe immunodeficiency are likely to undergo persistent infections, shed virus particles for prolonged periods, and lack an inflammatory or abortive phase, this represents an overall risk of morbidity and mortality from COVID-19. In cases suffering from HDMs, further investigation is needed to achieve a better understanding of triviruses and a group of related variants in patients with anemia and HDMs, as well as their treatment through vaccines, drugs, and other methods. Against this background, the present study aimed to delineate the relationship between HDMs and the novel COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Besides, effective treatment options for HDM cases were further explored to address this epidemic and its variants. Therefore, learning about how COVID-19 manifests in these patients, along with exploiting the most appropriate treatments, may lead to the development of treatment and care strategies by clinicians and researchers to help patients recover faster. Video Abstract.
Keywords: Anemia; COVID-19; Haematological disorders and malignancies; Immune response; SARS-CoV-2.